Recommendations are presented to assist primary care providers in identifying biliary atresia in newborns by 2 to 4 weeks of life.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Prucalopride, which effectively manages chronic idiopathic constipation, is less efficacious in patients with obesity and moderate renal impairment.

For infants born before 34 weeks of gestation and with a birth weight <1,000 g, probiotics are associated with reduced mortality.

Physician burnout and intentions to reduce clinical effort or leave one’s institution are results of poor control over specific aspects of work.

The withholding and removal of data on the CDC and FDA websites could negatively affect cancer research, American Cancer Society warns.

HealthDay News — Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in the Journal of the American Medical Association.

Food sensitization and allergy were more significantly associated with the gut bacterial genera found in infants who were 1 month old vs 1 week old.

The FDA has granted Fast Track designation to amezalpat (TPST-1120) for the treatment of patients with hepatocellular carcinoma.

A major recall of canned tuna sold in dozens of states has been issued amid potentially dangerous packaging defect concerns.

Many insured US patients living with IBD face challenges to health care access, which has resulted in them skipping or rationing medication.